Intrepid Labs
Healthcare biotechnology
AI- and robotics-enabled pharmaceutical drug formulation
Seed (latest publicly reported round: May 2025)
Intrepid Labs is a Toronto-based biotechnology company spun out of the University of Toronto that applies artificial intelligence, machine learning, robotics, and pharmaceutical formulation expertise to improve and accelerate drug-product development. Its Valiant platform is a closed-loop system that designs, tests, and optimizes formulations using automated experiments and experimental data. The company works with pharmaceutical developers, contract research organizations, and biotech companies. Its stated focus is formulation development—not discovery of drug molecules themselves.
Company Details
- Website
- intrepidlabs.tech
- Headquarters
- Toronto, Ontario, Canada
- Founded
- 2023
- Funding
- Over $11 million USD reported as of May 2025: a $7 million seed round led by AVANT BIO and an earlie
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring